Barclays PLC Pfizer Inc Transaction History

Barclays PLC

$288 Billion
Q1 2024

A detailed history of Barclays PLC transactions in Pfizer Inc stock. As of the latest transaction made, Barclays PLC holds 21,565,306 shares of PFE stock, worth $618 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

21,565,306

Previous 11,625,554 85.5%

Holding current value

$618 Million

Previous $335 Million 78.8%

% of portfolio

0.21%

Previous 0.12%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $257 Million - $296 Million	9,939,752 Added 85.5%	21,565,306 $598 Million
Q4 2023 Feb 15, 2024	SELL	$26.13 - $33.94 $118 Million - $153 Million	-4,503,233 Reduced 27.92%	11,625,554 $335 Million
Q3 2023 Nov 07, 2023	BUY	$32.09 - $37.51 $99.6 Million - $116 Million	3,102,892 Added 23.82%	16,128,787 $535 Million
Q2 2023 Aug 03, 2023	BUY	$36.12 - $41.79 $234 Million - $270 Million	6,466,670 Added 98.59%	13,025,895 $478 Million
Q1 2023 May 04, 2023	SELL	$39.39 - $51.28 $234 Million - $305 Million	-5,941,259 Reduced 47.53%	6,559,225 $268 Million

Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $138 Million - $180 Million	3,310,499 Added 36.02%	12,500,484 $641 Million
Q3 2022 Nov 03, 2022	BUY	$43.76 - $53.42 $87.2 Million - $106 Million	1,993,130 Added 27.69%	9,189,985 $402 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $192 Million - $228 Million	-4,125,023 Reduced 36.43%	7,196,855 $377 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $173 Million - $214 Million	-3,779,832 Reduced 25.03%	11,321,878 $586 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $23.7 Million - $35.2 Million	574,305 Added 3.95%	15,101,710 $892 Million
Q3 2021 Nov 09, 2021	BUY	$39.25 - $50.42 $175 Million - $225 Million	4,470,323 Added 44.45%	14,527,405 $625 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $52.4 Million - $59.4 Million	1,459,377 Added 16.97%	10,057,082 $394 Million
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $15.5 Million - $17.5 Million	-463,591 Reduced 5.12%	8,597,705 $311 Million
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $174 Million - $222 Million	-5,206,772 Reduced 36.49%	9,061,296 $334 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $185 Million - $217 Million	5,833,187 Added 69.16%	14,268,068 $524 Million
Q2 2020 Aug 12, 2020	BUY	$30.12 - $36.54 $1.04 Million - $1.26 Million	34,450 Added 0.41%	8,434,881 $276 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $121 Million - $173 Million	-4,467,374 Reduced 34.72%	8,400,431 $274 Million
Q4 2019 Feb 10, 2020	SELL	$32.92 - $37.36 $2.75 Million - $3.12 Million	-83,392 Reduced 0.64%	12,867,805 $504 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $27.7 Million - $35.9 Million	-851,292 Reduced 6.17%	12,951,197 $465 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $32.2 Million - $36.2 Million	-870,915 Reduced 5.94%	13,802,489 $598 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $48.7 Million - $53.5 Million	1,299,086 Added 9.71%	14,673,404 $623 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $31.8 Million - $36.3 Million	-827,042 Reduced 5.82%	13,374,318 $584 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $7.04 Million - $8.55 Million	-204,377 Reduced 1.42%	14,201,360 $626 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $34.2 Million - $36.5 Million	1,038,492 Added 7.77%	14,405,737 $523 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $74.7 Million - $86.6 Million	2,340,112 Added 21.22%	13,367,245 $474 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $58.7 Million - $62.3 Million	1,765,138 Added 19.06%	11,027,133 $399 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $287 Million - $316 Million	9,261,995	9,261,995 $331 Million

Others Institutions Holding PFE

# of Institutions

3,154

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $161B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account